Low ROE and net income growth remains a concern for the comp...
Low ROE and net income growth remains a concern for the company. Despite retaining profits, no earnings growth has followed, signaling other potential issues such as a business decline. Analyst forecasts suggest continued growth in earnings. The current share price may reflect this expected growth.
Is The Market Rewarding Cathay Biotech Inc. (SHSE:688065) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment